FDA Determines A “Class Effect” Is In Play For All NSAIDs
• By The Tan Sheet
An FDA decision to request revised safety labeling changes to OTC NSAIDs enables manufacturers to continue positioning the drugs as safer alternatives to their prescription counterparts, which will carry "black box" warnings going forward
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
